Flavien Devun

509 total citations
16 papers, 386 citations indexed

About

Flavien Devun is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Flavien Devun has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Flavien Devun's work include DNA Repair Mechanisms (9 papers), Cancer therapeutics and mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Flavien Devun is often cited by papers focused on DNA Repair Mechanisms (9 papers), Cancer therapeutics and mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Flavien Devun collaborates with scholars based in France, Switzerland and United States. Flavien Devun's co-authors include Marie Dutreix, Jian‐Sheng Sun, J. Biau, Anne Vincent‐Salomon, Julie Bellière, Brigitte Bourachot, Fatima Mechta‐Grigoriou, Virginie Mieulet, Tina Gruosso and Xavier Leverve and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

Flavien Devun

15 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flavien Devun France 11 307 137 69 56 28 16 386
Shu Lin China 8 238 0.8× 159 1.2× 102 1.5× 33 0.6× 25 0.9× 16 372
Laura Ghisolfi United States 7 219 0.7× 163 1.2× 115 1.7× 37 0.7× 15 0.5× 10 356
Sumit Das India 5 283 0.9× 175 1.3× 123 1.8× 59 1.1× 24 0.9× 6 468
Gaoyang Zhu China 9 323 1.1× 115 0.8× 95 1.4× 46 0.8× 20 0.7× 14 486
Naomi Brook Australia 5 271 0.9× 190 1.4× 94 1.4× 56 1.0× 25 0.9× 8 439
Yanbo Zheng China 11 169 0.6× 86 0.6× 69 1.0× 56 1.0× 18 0.6× 40 308
Vidusha Devasthali United States 5 245 0.8× 148 1.1× 85 1.2× 45 0.8× 15 0.5× 5 371
Nick A. Kuburich United States 7 260 0.8× 134 1.0× 117 1.7× 55 1.0× 33 1.2× 14 443
Joanna Zabkiewicz United Kingdom 9 329 1.1× 99 0.7× 70 1.0× 36 0.6× 22 0.8× 18 484
Jinwei Hao Australia 3 255 0.8× 197 1.4× 129 1.9× 92 1.6× 15 0.5× 3 432

Countries citing papers authored by Flavien Devun

Since Specialization
Citations

This map shows the geographic impact of Flavien Devun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavien Devun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavien Devun more than expected).

Fields of papers citing papers by Flavien Devun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavien Devun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavien Devun. The network helps show where Flavien Devun may publish in the future.

Co-authorship network of co-authors of Flavien Devun

This figure shows the co-authorship network connecting the top 25 collaborators of Flavien Devun. A scholar is included among the top collaborators of Flavien Devun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavien Devun. Flavien Devun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Herath, Nirmitha I., Flavien Devun, Aurélie Herbette, et al.. (2017). Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models. European Radiology. 27(10). 4435–4444. 11 indexed citations
2.
Thierry, Sylvain, Flavien Devun, Muthana Al Abo, et al.. (2016). Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. Clinical Cancer Research. 23(4). 1001–1011. 29 indexed citations
3.
Tourneau, C. Le, Brigitte Dréno, Youlia Kirova, et al.. (2016). First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma. British Journal of Cancer. 114(11). 1199–1205. 30 indexed citations
4.
Gruosso, Tina, Virginie Mieulet, Mélissa Cardon, et al.. (2016). Chronic oxidative stress promotes H2 AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Molecular Medicine. 8(5). 527–549. 126 indexed citations
5.
Biau, J., Flavien Devun, Pierre Verrelle, & Marie Dutreix. (2016). Dbait : un concept innovant pour inhiber la réparation de l’ADN et contribuer aux traitements des cancers. Bulletin du Cancer. 103(3). 227–235. 6 indexed citations
6.
Biau, J., Emmanuel Chautard, Franck Court, et al.. (2016). Global Conservation of Protein Status between Cell Lines and Xenografts. Translational Oncology. 9(4). 313–321. 10 indexed citations
7.
Herath, Nirmitha I., Flavien Devun, Aurélie Herbette, et al.. (2015). The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis. Molecular Cancer Therapeutics. 15(1). 15–22. 18 indexed citations
8.
Tourneau, Christophe Le, Brigitte Dréno, Youlia Kirova, et al.. (2015). First-in-human phase I study of the DNA repair inhibitor DT01 in combination with radiotherapy in patients with in transit melanoma.. Journal of Clinical Oncology. 33(15_suppl). 2555–2555. 1 indexed citations
9.
Devun, Flavien, Nirmitha I. Herath, Alban Denys, Jian‐Sheng Sun, & Marie Dutreix. (2015). DNA repair inhibition by DT01 as an adjuvant therapy at each stage of hepatocellular cancer (HCC) treatment.. Journal of Clinical Oncology. 33(3_suppl). 303–303. 2 indexed citations
10.
Biau, J., Flavien Devun, Maria Quanz, et al.. (2014). A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma. Neoplasia. 16(10). 835–844. 37 indexed citations
11.
Devun, Flavien, J. Biau, Michel Huerre, et al.. (2013). Colorectal Cancer Metastasis: The DNA Repair Inhibitor Dbait Increases Sensitivity to Hyperthermia and Improves Efficacy of Radiofrequency Ablation. Radiology. 270(3). 736–746. 23 indexed citations
12.
Devun, Flavien, et al.. (2013). Antitumor effect of DNA repair inhibitor DT01 combined with TACE on VX2 rabbit liver tumors. Journal of Vascular and Interventional Radiology. 24(7). 1080–1080.
13.
Schlegel, Anne, Cyril Buhler, Flavien Devun, et al.. (2012). Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol. Molecular Therapy — Nucleic Acids. 1. e33–e33. 11 indexed citations
14.
Bellière, Julie, Flavien Devun, Cécile Cottet‐Rousselle, et al.. (2012). Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death. Journal of Bioenergetics and Biomembranes. 44(1). 207–212. 19 indexed citations
15.
Devun, Flavien, Guilhem Bousquet, J. Biau, et al.. (2011). Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer. Journal of Gastroenterology. 47(3). 266–275. 18 indexed citations
16.
Devun, Flavien, Ludivine Walter, Julie Bellière, et al.. (2010). Ubiquinone Analogs: A Mitochondrial Permeability Transition Pore-Dependent Pathway to Selective Cell Death. PLoS ONE. 5(7). e11792–e11792. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026